Map-kinase-driven hematopoietic neoplasms: A decade of progress in the molecular age Review


Authors: Chakraborty, R.; Abdel-Wahab, O.; Durham, B. H.
Review Title: Map-kinase-driven hematopoietic neoplasms: A decade of progress in the molecular age
Abstract: Mutations in members of the mitogen-activated protein kinase (MAPK) pathway are exten-sively studied in epithelial malignancies, with BRAF mutations being one of the most common alterations activating this pathway. However, BRAF mutations are overall quite rare in hematological malignancies. Studies over the past decade have identified high-fre-quency BRAFV600E, MAP2K1, and other kinase alterations in two groups of MAPK-driven hematopoietic neoplasms: hairy cell leukemia (HCL) and the systemic histiocytoses. Despite HCL and histiocytoses sharing common molecular alterations, these are phenotypically distinct malignancies that differ in respect to clinical presentation and suspected cell of origin. The purpose of this review is to highlight the molecular advancements over the last decade in the histiocytic neoplasms and HCL and discuss the impact these insights have had on our understanding of the molecular pathophysiology, cellular origins, and therapy of these enig-matic diseases as well as perspectives for future research directions. © 2021 Cold Spring Harbor Laboratory Press; all rights reserved;.
Journal Title: Cold Spring Harbor Perspectives in Medicine
Volume: 11
Issue: 5
ISSN: 2157-1422
Publisher: Cold Spring Harbor Laboratory Press  
Date Published: 2021-05-01
Start Page: a034892
Language: English
DOI: 10.1101/cshperspect.a034892
PUBMED: 32601132
PROVIDER: scopus
PMCID: PMC7770072
DOI/URL:
Notes: Article -- Export Date: 1 June 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Benjamin Heath Durham
    117 Durham